Project Details
Description
ZZ-3K3A-301: A multicenter, randomized, placebo-controlled, double-blinded, Phase 3 study to evaluate the efficacy and safety of 3K3A-APC (RHAPSODY-2)
| Status | Active |
|---|---|
| Effective start/end date | 6/1/22 → 5/31/28 |
Funding
- UNIVERSITY OF CINCINNATI
- NIH NAT INST OF NEURO DISORDERS & STROKE
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.